Related references
Note: Only part of the references are listed.The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis
F. D. O'Shea et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
G. Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Efficacy and safety of TNF alpha antagonist therapy in patients with juvenile spondyloarthropathies
Moana Sulpice et al.
JOINT BONE SPINE (2009)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort
L. S. Gensler et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis:: a multicentre randomised controlled trial
J. Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Anti-tumor necrosis factor a blockade in the treatment of juvenile spondylarthropathy
SML Tse et al.
ARTHRITIS AND RHEUMATISM (2005)
Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis
M Stone et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
The German etanercept registry for treatment of juvenile idiopathic arthritis
G Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Infliximab in two patients with juvenile ankylosing spondylitis
H Schmeling et al.
RHEUMATOLOGY INTERNATIONAL (2004)
Recombinant human tumor necrosis factor receptor, (etanercept) for treating ankylosing spondylitis - A randomized, controlled trial
JC Davis et al.
ARTHRITIS AND RHEUMATISM (2003)
Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis:: an open label study
P Lahdenne et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management
MA Gardam et al.
LANCET INFECTIOUS DISEASES (2003)
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis - Interim results from an ongoing multicenter, open-label, extended-treatment trial
DJ Lovell et al.
ARTHRITIS AND RHEUMATISM (2003)
A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies
R Burgos-Vargas et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
